Anterior and Posterior Approaches of Suprascapular Nerve Block

Postoperative Pain Clinical Trial

Official title:

Comparison of Anterior and Posterior Approaches of Suprascapular Nerve Block in Arthroscopic Shoulder Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05442814
• Other study ID #: EDinc
• Status: Completed
• Phase: N/A
• Start date: March 15, 2022
• Est. completion date: March 15, 2023

Study information

• Verified date: March 2024
• Source: Istanbul Medeniyet University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Suprascapular nerve is a mixed motor and sensory peripheral nerve arising from the superior trunk of brachial plexus.The suprascapular nerve runs through the posterior triangle of the neck, anterior of the trapezius muscle and dorsal of the omohyoid muscle, in direction of the scapula. Suprascapular nerve block is performed by anterior and posterior approach. Posterior approach of the suprascapular nerve block has been shown for many years to provide effective analgesia in the shoulder region for the chronic and acute pain. There are studies showing that suprascapular block with anterior approach provides effective analgesia in shoulder arthroscopy. The aim of our study was to compare anterior and posterior approaches of suprascapular nerve block in terms of analgesic efficacy and patient safety.

Description:

This study is a prospective randomized clinical trial will be conducted between March 2022 and March 2023.Participant will divide into two groups as participant who underwent suprascapular nerve block with the anterior approach and participant who underwent suprascapular nerve block with the posterior approach. Bupivacaine 5 ml %0.5 will be injected both group. Diaphragmatic thickness fraction will be evaluated with ultrasound left and right 7.-8. subcostal anterior axillary border with the participant with the semi-sitting position. Diaphragmatic thickness fraction will measure before the block and after 30 minutes the surgery. Participants will administered intravenous morphine patient controlled analgesia for 24 hours stay. The amount of opioid analgesics given in both groups will be determined (in mg). Postoperative 4th, 6th, 12th, 24th hour Visual Analogue Scale scores of the participants and opioid consumptions until that hours will be evaluated. An addition participant will be determined according to the surgery.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: March 15, 2023
• Est. primary completion date: March 15, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patient who accepts to study protocol
• Scheduled for shoulder surgery
• Between the ages of 18 and 80

Exclusion Criteria:

• Patients with coagulopathy
• Patients with a history of local anesthetic drug allergy and toxicity
• Patients with advanced organ failure
• Patients with mental retardation
• Patients with infection present at the injection site
• Patients with diaphragm paralysis
• Pregnant patients

Related Conditions & MeSH terms

• Anterior Suprascapular Nerve Block
• Diaphragmatic Paralysis
• Pain, Postoperative
• Paralysis
• Postoperative Pain
• Respiratory Paralysis
• Shoulder Pain
• Suprascapular Nerve Block

Intervention

Procedure:
• Posterior suprascapular block
Diaphragmatic thickness fraction will be evaluated in the participant underwent suprascapular block performed by posterior approach
• Anterior suprascapular block
Diaphragmatic thickness fraction will be evaluated in the participant underwent suprascapular block performed by anterior approach

Locations

Country	Name	City	State
Turkey	Istanbul Medeniyet University	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul Medeniyet University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postoperative pain at the first postoperatively 30th. Min.	Visual analog scale (1-10): 1= no pain, 10= the worst pain ever feel.	The first postoperative 30 minutes
Secondary	Diaphragmatic movements	Ratio of diaphragm thickness in end-inspiration and end-expiration measured by ultrasonography	Baseline (Before the block performed) and 30 minutes after the end of surgery
Secondary	Peroperatively opioid analgesic consumption (Remifentanil)	milligram	postoperative 0th.min
Secondary	Postoperative opioid analgesic consumption (morphine)	milligram	postoperative 30th. Min
Secondary	Postoperative opioid analgesic consumption (morphine)	milligram	postoperative 4 hours
Secondary	Postoperative opioid analgesic consumption (morphine)	milligram	postoperative 6 hours
Secondary	Postoperative opioid analgesic consumption (morphine)	milligram	postoperative 12 hours
Secondary	Postoperative opioid analgesic consumption (morphine)	milligram	postoperative 24 hours
Secondary	Postoperative pain at postoperative 4th. Hours	Visual analog scale (1-10): 1= no pain, 10= the worst pain ever feel.	at postoperative 4th. Hours
Secondary	Postoperative pain at postoperative 6th. Hours	Visual analog scale (1-10): 1= no pain, 10= the worst pain ever feel.	at postoperative 6th. Hours
Secondary	Postoperative pain at postoperative 12th. Hours	Visual analog scale (1-10): 1= no pain, 10= the worst pain ever feel.	at postoperative 12th. Hours
Secondary	Postoperative pain at postoperative 24th. Hours	Visual analog scale (1-10): 1= no pain, 10= the worst pain ever feel.	at postoperative 24th. Hours